Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
depression
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alector
alkermes
antidepressant
antisense oligonucleotide
assurex health
avrobio
baricitinib
bcma
benzodiazepines
biogen
blackstone group
What
new
3
×
genetic
aims
backed
bio
biopharma
cancer
cause
centers
ceo
congress
congressional
crispr
cut
depression
drugs
epilepsy
event
executives
feud
genes
group
guesswork
guide
helps
isn’t
known
later
links
major
making
marcio
medical
medicine
medicines
month
mutations
neuro
ny
pharma
Language
unset
Current search:
depression
×
new
×
" boston blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?